We are live on ! Find out more
IRD

Opus Genetics
IRD

34 hedge funds and large institutions have $3.21M invested in Opus Genetics in 2015 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

43% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 7

10% more funds holding

Funds holding: 31 → 34 (+3)

25% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 4

30% less capital invested

Capital invested by funds: $4.56M → $3.21M (-$1.35M)

Holders
34
Holders Change
+3
Holders Change %
+9.68%
% of All Funds
0.89%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
3
Reduced
4
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$191K
2
HVIA
Hudson Valley Investment Advisors
New York
+$88.7K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$16.8K
4
TSS
Two Sigma Securities
New York
+$15.9K
5
BFA
BlackRock Fund Advisors
California
+$13K

Top Sellers

Rank Fund Capital Flow
1
Wells Fargo
Wells Fargo
California
-$205K
2
CCM
Condor Capital Management
New Jersey
-$110K
3
Nomura Holdings
Nomura Holdings
Japan
-$30K
4
AT
Arden Trust
Delaware
-$26K
5
VKH
Virtu KCG Holdings
New York
-$14.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.78M +$16.8K +79 +0.8%
Renaissance Technologies
2
Renaissance Technologies
New York
$460K +$191K +898 +52%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$332K – – –
BIT
4
BlackRock Institutional Trust
California
$121K – – –
Northern Trust
5
Northern Trust
Illinois
$77K – – –
HVIA
6
Hudson Valley Investment Advisors
New York
$73K +$88.7K +417 New
NFC
7
Northeast Financial Consultants
Connecticut
$54K – – –
Bank of New York Mellon
8
Bank of New York Mellon
New York
$53K – – –
VKH
9
Virtu KCG Holdings
New York
$52K -$14.9K -70 -19%
BMC
10
Benin Management Corp
Connecticut
$30K – – –
SBIA
11
Sheaff Brock Investment Advisors
Indiana
$25K +$30.8K +145 New
BA
12
BlackRock Advisors
Delaware
$16K – – –
Goldman Sachs
13
Goldman Sachs
New York
$15K – – –
State Street
14
State Street
Massachusetts
$15K – – –
TSS
15
Two Sigma Securities
New York
$13K +$15.9K +75 New
GC
16
Guggenheim Capital
Illinois
$12K – – –
Cambridge Investment Research Advisors
17
Cambridge Investment Research Advisors
Iowa
$12K +$9.78K +46 +184%
BFA
18
BlackRock Fund Advisors
California
$11K +$13K +61 New
Creative Planning
19
Creative Planning
Kansas
$10K – – –
ASN
20
Advisory Services Network
Georgia
$8K – – –
FHC
21
First Heartland Consultants
Missouri
$8K – – –
Susquehanna International Group
22
Susquehanna International Group
Pennsylvania
$7K +$8.08K +38 New
Citadel Advisors
23
Citadel Advisors
Florida
$6K -$9.57K -45 -56%
UBS Group
24
UBS Group
Switzerland
$4K -$425 -2 -9%
ICOA
25
Investment Centers of America
North Dakota
$4K +$4.47K +21 New
1
2

IRD Hedge Fund Activity: Q4 2015 in Review

34 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Opus Genetics (IRD) for Q4 2015, worth a combined $3.21M — down 30% from $4.56M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new IRD positions and 7 closed out — a net gain of 3 holders — while 3 added to existing stakes and 4 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $191K. The largest seller was Wells Fargo, exiting entirely with an estimated $205K sold.

  • 34 institutional investors held Opus Genetics (IRD) as of Q4 2015, up from 31 in Q3 2015.
  • Funds reported $3.21M of Opus Genetics stock for Q4 2015, down 30% quarter-over-quarter.
  • 10 funds opened new Opus Genetics positions in Q4 2015 and 7 closed out, a net change of +3 holders.
  • The largest Opus Genetics buyer in Q4 2015 was Renaissance Technologies, an estimated $191K added.
  • The largest Opus Genetics seller in Q4 2015 was Wells Fargo, an estimated $205K sold.

Based on aggregated 13F filings for Q4 2015.